Technical Analysis – EURUSD aims for uptrend extension after FOMC boost



EURUSD advanced to a ten-month high of 1.1032 in the wake of a less hawkish FOMC policy statement late on Wednesday, which telegraphed that monetary tightening is probably having the desired impact on inflation.

The pair mildly trimmed some gains earlier today, edging slightly below the 1.1000 level as the RSI and the stochastics on the four-hour chart flagged overbought conditions.

While a pause can be reasonable after the latest spike, yesterday’s close above the 1.0940 bar, which overlaps with the 50% Fibonacci retracement of the 1.2348-0.9535 downtrend, is feeding optimism that the recovery will probably continue towards the key resistance line from November at 1.1115. Before it reaches that place, some congestion may develop around 1.1050. Should the bulls cross above the trendline, they may next target March’s high of 1.1185.

In case downside pressures persist, the price may revisit the 1.0940 region. The 20- and 50-period exponential moving averages (EMAs), which have been limiting bearish actions since mid-January, are approaching that territory and could prevent a forceful decline below the 1.0900 round level. This is also where the 23.6% Fibonacci retracement of the latest upleg from 1.0480 is located. If the bears dominate, the spotlight will immediately fall on the ascending trendline from November 3 around 1.0850 and the 1.0820 region. Even lower, another support trendline from November 21 could halt the bears near 1.0760.

In summary, EURUSD is expected to push for fresh highs in the short term, although some profit-taking is possible following the latest quick rally in the market. 

Latest News

Technical Analysis – USDJPY finds support ahead of FOMC, but bears still loom

U

G

Technical analysis – NZDUSD stuck in range ahead of Fed meeting

N

Technical Analysis – EURGBP recoups weekly losses; stays below key barrier

E

A

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.